Pharmaceutical Technology

JANUARY 16, 2023

While the biopharmaceutical industry has been impacted and pressured by various factors such as the Covid-19 pandemic, inflation, the Ukraine-Russia war, ongoing supply chain issues, and a challenging economic environment, collaboration between pharma companies and emerging technologies providers continues to grow, especially in the research and development (R&D) field, offering some resilience in times of geopolitical and economic disruptions.

Pharmaceutical Companies 121

Pharmaceutical Companies Pharmaceutical Companies Vaccines 121

PhRMA

JANUARY 17, 2023

The Inflation Reduction Act’s (IRA’s) drug price setting provisions, as predicted, are already impacting biopharmaceutical research & development (R&D) decisions. Whether you are looking at estimates of how many fewer medicines or indications will be developed, or noting shifts away from areas of unmet patient need because the law is signaling those innovations are not valued, the IRA’s price setting provisions are a loss for patients everywhere.

228

228

Drug Topics

JANUARY 17, 2023

The updates include new recommendations for COVID-19 and pneumococcal vaccines.

Immunization 201

Immunization Vaccines 201

Pharmacy Times

JANUARY 20, 2023

Antibodies help neutralize the virus, though the levels decrease at the 6-month mark, data indicate.

Vaccines 167

Vaccines 167

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

STAT

JANUARY 18, 2023

Yet another experimental HIV vaccine has failed. The National Institute of Allergy and Infectious Diseases reported Wednesday that a Phase 3 clinical trial of a vaccine was stopped because the vaccine was ineffective at preventing HIV infection. The vaccine was being developed by Janssen, the vaccine division of Johnson & Johnson.

Vaccines 145

Vaccines 145

PhRMA

JANUARY 19, 2023

This January, PhRMA joined health care leaders, investors, R&D experts and members of the media at the 2023 J.P. Morgan Health Care Conference in San Francisco, CA. During this week, we discussed ways to improve patient outcomes, access and affordability in our health care system.

197

197

Pharmacy Times

JANUARY 17, 2023

Vaccination provides an opportunity to prevent and treat herpes simplex virus infection.

Vaccines 167

Vaccines 167

STAT

JANUARY 18, 2023

With a few clicks, Daniel added the chemical to his online cart and ordered it. In less than a week, a vial containing white powder arrived at his house. He used a syringe to measure out sterile water and eject it into the vial to dissolve the powder. Then, with a different syringe, he drew up about a quarter of a milliliter of the solution and injected it into his lower abdomen.

143

143

Fierce Healthcare

JANUARY 20, 2023

Dollar General pilots mobile clinics as it targets a bigger presence in healthcare hlandi Fri, 01/20/2023 - 18:25

140

140

Drug Topics

JANUARY 18, 2023

Previously hepatitis B vaccines have offered lower levels of protection for people living with HIV. New research indicates that a 3-dose series could offer much better protection.

Vaccines 187

Vaccines 187

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JANUARY 16, 2023

The head of the CAR T cell antibody can recognize and target the growth factor in its tumor microenvironment.

FDA 162

FDA 162

STAT

JANUARY 19, 2023

Today’s teens and tweens have never known a world without social media. There are still a lot of open questions about how sites like TikTok and Instagram may shape their development — and stories focusing on the potential negative impacts of social media tend to dominate the news. But a recent study published in JAMA Pediatrics is the latest in a growing body of research that suggests the relationship that young people have with social media is too complicated to be categorized as

140

140

Fierce Healthcare

JANUARY 18, 2023

Healthcare ranked lowest for employee satisfaction, Qualtrics survey finds aburky Wed, 01/18/2023 - 16:40

138

138

Drug Topics

JANUARY 18, 2023

A recent study found a rise in the prevalence of antipsychotic prescriptions among pediatric patients and noted which antipsychotics were most commonly used for specific indications.

187

187

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JANUARY 19, 2023

Data from a randomized clinical trial supports previous clinical findings on SGLT2 inhibitors and their ability to slow the progression of chronic kidney disease.

158

158

Fierce Pharma

JANUARY 20, 2023

JPM23: Pfizer, Moderna and more look to combine COVID and flu vaccine markets zbecker Fri, 01/20/2023 - 14:48

Vaccines 136

Vaccines 136

Fierce Healthcare

JANUARY 19, 2023

UnitedHealthcare launches behavioral health coaching program for commercial plans pminemyer Thu, 01/19/2023 - 15:05

137

137

Drug Topics

JANUARY 18, 2023

The FDA has approved another Tdap vaccine option for use during pregnancy to prevent pertussis, otherwise known as whooping cough.

Vaccines 187

Vaccines FDA 187

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JANUARY 16, 2023

Providers use "Kitchen Sink Approach" because cure proves elusive, symptomatic treatment is sketchy.

158

158

STAT

JANUARY 17, 2023

Increased injection drug use has led to a spike in cases of the life-threatening heart condition endocarditis , with cases rapidly accelerating since the onset of Covid-19. The increased case count is one of the lesser-known side effects of the deadly addiction epidemic. But patients with endocarditis, an inflammation of the heart lining caused by infection, require complex, thoughtful care — care that the U.S. health system is ill-equipped to provide.

Hospitals 132

Hospitals 132

Fierce Healthcare

JANUARY 18, 2023

New Jefferson Health program enables clinical, academic nurses to partner on research agliadkovskaya Wed, 01/18/2023 - 14:16

137

137

Drug Topics

JANUARY 16, 2023

Pharmaceutical makers, price managers out of control with ‘necessary drug’ for millions, Attorney General says.

187

187

Pharmacy Times

JANUARY 19, 2023

There is a lack of funding for attention-deficit hyperactivity disorder and coinciding psychological research compared to the funds generated for autism research.

148

148

Fierce Pharma

JANUARY 17, 2023

CDC probes possible safety risk for Pfizer's new COVID shot, sees no need to change vaccine practices. zbecker. Tue, 01/17/2023 - 11:49.

Vaccines 131

Vaccines 131

Fierce Healthcare

JANUARY 18, 2023

Black patients get better care when nurse practitioners have full practice authority: study. fdiamond. Wed, 01/18/2023 - 15:46.

136

136

Drug Topics

JANUARY 20, 2023

The PDUFA date has been set for May 22, 2023.

FDA 187

FDA 187

Pharmacy Times

JANUARY 16, 2023

Significant study results may help inform clinical practice strategies.

141

141

Fierce Pharma

JANUARY 18, 2023

AbbVie, Novartis and more win national coverage in China even as Pfizer's Paxlovid gets left out. aliu. Wed, 01/18/2023 - 14:00.

130

130

Fierce Healthcare

JANUARY 20, 2023

Employers should carefully weigh benefits of high-deductible health plans: study fdiamond Fri, 01/20/2023 - 07:19

131

131

Drug Topics

JANUARY 17, 2023

Childhood vaccinations took a downturn during the pandemic. Now is the time to get them done and pharmacists can help.

Vaccines 179

Vaccines 179

Pharmacy Times

JANUARY 19, 2023

Dr Mancini navigates challenges inhibiting patients to receive optimal care amid diagnosis of MDS.

139

139

PhRMA

JANUARY 17, 2023

Last summer, the United States and Taiwan launched the U.S.-Taiwan Initiative on 21st-Century Trade to deepen economic and trade relations. In detailed comments to the U.S. Trade Representative (USTR), PhRMA encouraged the Biden administration to pursue an agreement that is as comprehensive and ambitious as possible to the benefit of both American and Taiwanese citizens.

130

130

STAT

JANUARY 17, 2023

Moderna’s vaccine against the respiratory syncytial virus, or RSV, reduced the rate of lower respiratory disease in people over 60 in a Phase 3 trial, the company said Tuesday. The result will increase competition in a soon-to-be crowded market. The drug giants Pfizer and GlaxoSmithKline have already presented results for their RSV vaccines in older individuals, and have been preparing for what could be a brisk marketing battle.

Vaccines 129

Vaccines 129